Skip to main content

Table 1 Demographics and clinical data of the cohort

From: Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

 

Controls (n = 216)

Scleroderma patients (n = 444)

Age (years)

51 ± 14 years

53 ± 12.1

Gender

  

   Male

117 (54%)

56 (13%)

   Female

99 (46%)

388 (87%)

Scleroderma phenotype

  

   Limited

 

241 (54%)

   Diffuse

 

200 (45%)

Disease duration (years)

 

6.9 ± 0.3

Systemic sclerosis-association autoantibodies

  

   Anti-centromere

 

109 (25%)

   Anti-topoisomerase

 

112 (25%)

   Anti-RNA polymerase III

 

109 (25%)

  1. Data presented as mean ± standard deviation or n (%).